Last update 21 Nov 2024

XKH-001

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Target
IL-25
Mechanism
IL-25 inhibitors(interleukin 25 inhibitors)
Therapeutic Areas
Immune System DiseasesRespiratory DiseasesCongenital Disorders+ [1]
Active Indication
Dermatitis, AtopicAsthmaAllergic asthma+ [2]
Inactive Indication
Inflammation
Originator Organization
Beijing Kanova Biopharmaceutical Co., Ltd.
Active Organization
Beijing Kanova Biopharmaceutical Co., Ltd.Suzhou Xinkanghe Biomedical Technology Co., Ltd.Suzhou Xinkanghe Biomedical Technology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

6
Clinical Trials associated with XKH-001
NCT05991661 / Not yet recruitingPhase 1/2
A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Phase Ib Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of XKH001 Injection in Healthy Subjects
CTR20233355 / Active, not recruitingPhase 1
一项评估XKH001注射液在过敏性哮喘患者多次给药后对气道高反应性的影响、安全性、免疫原性、药代动力学和药效动力学特征的单臂Ic期临床试验
[Translation] A single-arm Phase Ic clinical trial to evaluate the effects of XKH001 injection on airway hyperresponsiveness, safety, immunogenicity, pharmacokinetic and pharmacodynamic characteristics after multiple doses in patients with allergic asthma
CTR20230798 / CompletedPhase 1
一项评估XKH001注射液在健康受试者中的安全性、耐受性和药代动力学的随机、双盲、安慰剂对照、多次给药剂量递增的Ib期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multiple-dose escalation Phase Ib clinical trial to evaluate the safety, tolerability and pharmacokinetics of XKH001 injection in healthy subjects
100 Clinical Results associated with XKH-001
Login to view more data
100 Translational Medicine associated with XKH-001
Login to view more data
100 Patents (Medical) associated with XKH-001
Login to view more data
100 Deals associated with XKH-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, AtopicPhase 2
CN
Suzhou Xinkanghe Biomedical Technology Co., Ltd.Suzhou Xinkanghe Biomedical Technology Co., Ltd.
01 Nov 2024
AsthmaPhase 2-
Beijing Kanova Biopharmaceutical Co., Ltd.
01 Dec 2023
Allergic asthmaPhase 1
CN
Beijing Kanova Biopharmaceutical Co., Ltd.
01 Dec 2023
Moderate asthmaPhase 1
CN
Beijing Kanova Biopharmaceutical Co., Ltd.
14 Jun 2022
Severe asthmaPhase 1
CN
Beijing Kanova Biopharmaceutical Co., Ltd.
14 Jun 2022
HypersensitivityPreclinical
US
Beijing Kanova Biopharmaceutical Co., Ltd.
21 Aug 2021
InflammationPreclinical
US
Beijing Kanova Biopharmaceutical Co., Ltd.
21 Aug 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free